These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9316336)
21. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
22. A clinical focus on statins. Auer J; Eber B Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709 [TBL] [Abstract][Full Text] [Related]
23. The case for medical treatment in chronic stable coronary artery disease. Nash DT Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414 [No Abstract] [Full Text] [Related]
24. [Statins: possibly more than just lowering of the lipid level]. Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742 [TBL] [Abstract][Full Text] [Related]
25. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Morrison DA; Sacks J Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526 [TBL] [Abstract][Full Text] [Related]
33. Statins in the medical management of postoperative coronary artery bypass. Alexander JC Chest; 2005 Feb; 127(2):423-4. PubMed ID: 15705974 [No Abstract] [Full Text] [Related]
34. Review of the major intervention trials of lowering coronary artery disease risk through cholesterol reduction. Stark RM Am J Cardiol; 1996 Sep; 78(6A):13-9. PubMed ID: 8875970 [TBL] [Abstract][Full Text] [Related]
35. Should intensive cholesterol lowering play a role in the management of acute coronary syndromes? Waters DD; Azar RR Am J Cardiol; 2000 Oct; 86(8B):35J-42J; discussion 42J-43J. PubMed ID: 11081447 [TBL] [Abstract][Full Text] [Related]
36. Regression of coronary artery disease as a result of intensive lipid-lowering therapy. N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188 [No Abstract] [Full Text] [Related]
37. Cholesterol lowering and coronary vasomotion. Jialal I N Engl J Med; 1995 Aug; 333(5):324-5. PubMed ID: 7596390 [No Abstract] [Full Text] [Related]
38. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Kinlay S; Ganz P Am J Cardiol; 1997 Nov; 80(9A):11I-16I. PubMed ID: 9375937 [TBL] [Abstract][Full Text] [Related]
39. From heart surgery to prevention. Sprecher DL Am J Cardiol; 1998 Nov; 82(10B):66T-71T. PubMed ID: 9860379 [TBL] [Abstract][Full Text] [Related]
40. Endothelial function as a therapeutic target in coronary artery disease. Sharma N; Andrews TC Curr Atheroscler Rep; 2000 Jul; 2(4):303-7. PubMed ID: 11122758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]